Skip to main content
World Journal of Cardiology logoLink to World Journal of Cardiology
. 2023 Oct 26;15(10):518–530. doi: 10.4330/wjc.v15.i10.518

Cardiovascular complications following medical termination of pregnancy: An updated review

Tejveer Singh 1, Ajay K Mishra 2, Nikhil Vojjala 3, Kevin John John 4, Anu A George 5, Anil Jha 6, Michelle Hadley 7
PMCID: PMC10600792  PMID: 37900907

Abstract

BACKGROUND

Around 1 million cases of medical termination of pregnancy (MTP) take place yearly in the United States of America with around 2 percent of this population developing complications. The cardiovascular (CVD) complications occurring post MTP or after stillbirth is not very well described.

AIM

To help the reader better understand, prepare, and manage these complications by reviewing various cardiac comorbidities seen after MTP.

METHODS

We performed a literature search in PubMed, Medline, RCA, and google scholar, using the search terms “abortions” or “medical/legal termination of pregnancy” and “cardiac complications” or “cardiovascular complications”.

RESULTS

The most common complications described in the literature following MTP were infective endocarditis (IE) (n = 16), takotsubo cardiomyopathy (TTC) (n = 7), arrhythmias (n = 5), and sudden coronary artery dissection (SCAD) (n = 4). The most common valve involved in IE was the tricuspid valve in 69% (n = 10). The most observed causative organism was group B Streptococcus in 81% (n = 12). The most common type of TTC was apical type in 57% (n = 4). Out of five patients developing arrhythmia, bradycardia was the most common and was seen in 60% (3/5) of the patients. All four cases of SCAD-P type presented as acute coronary syndrome 10-14 d post termination of pregnancy with predominant involvement of the right coronary artery. Mortality was only reported following IE in 6.25%. Clinical recovery was reported consistently after optimal medical management following all these complications.

CONCLUSION

In conclusion, the occurrence of CVD complications following pregnancy termination is infrequently documented in the existing literature. In this review, the most common CVD complication following MTP was noted to be IE and TTC.

Keywords: Cardiovascular complications, Termination of pregnancy, Infective Endocarditis, Stress cardiomyopathy, Outcome


Core Tip: The most common cardiovascular complications following the medical termination of pregnancy (MTP) are infective endocarditis (IE) and takotsubo cardiomyopathy (TTC). The most common organism identified in IE is group B Streptococcus and the tricuspid valve is the most common valve involved. TTC occurs most commonly in the first trimester after MTP. Spontaneous coronary artery dissection mostly presents with chest pain and the right coronary artery is the most common vessel to be involved. Bradyarrhythmia is the most common arrhythmia noted. These patients improve with appropriate medical management and mortality tends to be low.

INTRODUCTION

The legality of abortion and the various restrictions imposed on the procedure vary significantly among various states of the United States and are ever-changing. The initial law, Roe vs Wade, which was made in 1973, streamlined the decision-making process. Over the last 50 years, there has been a paradigm change in the perspective of patients regarding the termination of pregnancy in the United States. Centers for Disease Control (CDC) reports an abortion rate of 11.4 for the year 2020 with around 1 million abortions taking place annually in the United States. Around 2% of this population have been reported to develop complications[1].

Due to the recent identification of female-specific factors associated with a greater cardiovascular (CVD) risk, it provides the potential to implement effective and targeted preventative measures to decrease disease burden at an individual and population level[2]. Therefore, having an understanding of the female specific risk stratification and prevention is important. Recent CVD risk guidelines have included miscarriage and stillbirth as risk factors for women[3]. Because of the changing times and laws, we must highlight various CVD complications which are associated with the termination of pregnancy[4]. In this article, we review the various cardiac comorbidities reported after the medical termination of pregnancy (MTP). We also describe their clinical profile, management, and outcomes observed in these patients. Various systemic reviews discuss the complications associated with the termination of pregnancy. However, none describes cardiac complications following the same. Therefore, this article can contribute towards a better understanding, and facilitate preparedness and management of the cardiac complications following termination of pregnancy.

MATERIALS AND METHODS

In this review, we aimed to describe the demographic details, clinical presentation, diagnosis, and management of the various CVD complications following MTP. We used the meta-analysis guidelines for the material and methodology of our study.

Search strategy

We performed a systemic search in various bibliographic databases including PubMed, Medline, RCA, and google scholar databases, using the search terms “abortions” or “medical/legal termination of pregnancy” and “cardiac complications” or “cardiovascular complications”. The reference citation analysis tool was also used to find more articles. We screened references of the initial articles for identifying other relevant articles. Search strategies were tailored to each database for identifying relevant articles. All search outputs were exported to Microsoft Excel version 2022. For those articles where the main text was missing, we reached out to the authors. We acknowledge their support in sharing their work with us.

Study selection

All articles reported in English including adult patients (age > 18 years) published before August 2022, were eligible to be included in this review. Articles lacking clinical details, including comments, opinions, and letters, were excluded. The inclusion and exclusion criteria for the patients were established in advance before the initiation of the study. To be included in this review, articles had to provide clinical details of the pregnancy and the reported cardiac complication. For those articles where the main text was missing, we directly contacted the authors. We acknowledge their support in sharing their work with us. We added complete information on the studies included in this study. Two reviewers independently screened the abstracts. Cardiac complications had to fulfill the diagnostic definitions as described below.

Definitions

Infective endocarditis: Cases of infectious endocarditis (IE) had to fulfill the Modified Duke’s criteria, which include the presence of either a blood culture of the organism consistent with IE or an echocardiogram showing positive evidence of IE, abscess, new partial dehiscence of a prosthetic valve, or new regurgitation (major criteria). Minor criteria include a previous heart condition or history of intravenous drug use, fever, presence of microorganisms not typically seen with IE, immunological phenomena such as glomerulonephritis, Roth spots, or vascular phenomena such as major arterial emboli or Janeway lesions. The presence of two major criteria, one major and three minors, or five minor criteria is diagnostic for definitive IE[5].

Takotsubo cardiomyopathy: Cases of takotsubo cardiomyopathy (TTC) had to fulfill the Mayo Clinic diagnostic criteria, which include: (1) Transient left ventricular systolic dysfunction with regional wall motion abnormalities extending beyond a single epicardial coronary distribution; (2) Absence of obstructive coronary disease or any angiographic evidence of acute plaque rupture; (3) Presence of new electrocardiogram (EKG) changes as either sinus tachycardia (ST)-segment elevation and/or T wave inversion or elevation in cardiac troponin levels; and (4) Documentation of absence of pheochromocytoma or myocarditis[1].

Spontaneous coronary artery dissection: Cases of spontaneous coronary artery dissection (SCAD) had to provide details of coronary angiography, which used an iodinated contrast agent to fill the lumen of coronary arteries and X-rays to image the lumen. Alternatively, if an alternate imaging modality such as optical coherence tomography or intravascular ultrasound was used to delineate the cause of narrowing and showed a tear or blood accumulation in the arterial wall, it would also be eligible for inclusion[6].

Cardiac arrhythmia: To be included in this review, reported arrhythmias had to have details of an investigation showing the pattern of the arrhythmia[7].

Risk and bias assessment: Two reviewers (Singh T and Vojjala N) independently screened for risk of error and bias in the articles. Disagreements were resolved through final verification and consensus of the third reviewer (Mishra AK)[8].

Data extraction: Extracted data include information on the publication year, authors, study type, and methodology. We also extracted data on study participants, including recent age, gender, clinical presentation, CVD, imaging, and laboratory parameters and management. Finally, we studied the outcomes, including CVD complications and mortality[9,10].

Data synthesis and analysis: Continuous variables are expressed as the mean or percentages. Given the small sample size under each subgroup, we were not able to identify any odds or associations.

RESULTS

The initial screening identified 300 cases that were published between 1990 and 2022, of which 34 fulfilled the inclusion criteria, as shown in the PRISMA diagram (Figure 1). These included 16 cases of IE, seven cases of TTC, six cases of arrhythmia, and five cases of SCAD. The clinical profile, management, and outcomes of these events are described in Tables 1-4[11-41].

Figure 1.

Figure 1

Flow diagram of study participant inclusion. SCAD: Sudden coronary artery dissection.

Table 1.

Patients with infective endocarditis following medical termination of pregnancy

No.
Age/details
Time interval
Antibiotic prophylaxis
Microbiological diagnosis
Valves involved
Other complications
Management
Final outcome
Ref.
1 17 yr/clandestine abortion 28 d No Neg TV None Mx Survived [10]
2 30 yr/post ciprofloxacin and doxycycline 10 d No GBS MV S Ar, R Ar Mx, MVR Survived [11]
3 31 yr/post-surgical abortion 48 d No GBS TV STE Mx, TVR Survived [12]
4 37 yr/post-surgical abortion, past history of AVR/MVR for IE 60 d Yes (ampicillin and gentamycin) GBS AV SE Mx Survived [13]
5 18 yr/elective abortion Several weeks No GBS TV SE Mx Survived [14]
6 30 yr/elective abortion 28 d No GBS TV SE, 1st HB Mx, TVR Survived [15]
7 33 yr/elective abortion 28 d No GBS TV SE, VRA Mx, TVR Survived [16]
8 24 yr/elective abortion 28 d No GBS TV SE, RHF Mx Survived [17]
9 15 yr/elective abortion 7 d Doxycycline GBS PV SE, PAA Mx, PVR Survived [18]
10 15 yr/elective abortion 11 d Ciprofloxacin + doxycycline GBS AV HF, AR Mx, AVR Survived [19]
11 18 yr/elective abortion 14 d Doxycycline GBS TV SE Mx, Emb Survived [20]
12 22 yr/elective abortion 7 d - GBS TV SE, PAA, TR Mx Lost to follow-up [21]
13 Young female - - - Mu - Mx, AVR, TVR Death [22]
14 37 yr 11 d - GBS TV SE, SI Mx Survived [23]
15 25 yr/rheumatic heart disease 14 d - MSSA Mu SE Mx Survived [24]
16 21 yr 21 d - E coli MV HF Mx, MVR Survived [25]

GBS: Group B streptococcus; MSSA: Methicillin sensitive staphylococcus aureus; MV: Mitral valve; TV: Tricuspid valve; AV: Aortic valve; PV: Pulmonary valve; Mu: Multiple valves involved; S Ar: Septic arthritis; R Ar: Reactive arthritis; STE: Septic thromboembolism; SE: Septic embolism; 1st HB: First degree heart block; VRA: Valve ring abscess; RHF: Right heart failure; PAA: Pulmonary artery aneurysm; HF: Heart failure; TR: Tricuspid regurgitation; AR: Aortic regurgitation; SI: Sacroilitis; Mx: Medical management; MVR: Mitral valve replacement; PVR: Pulmonary valve replacement; AVR: Aortic valve replacement; Emb: Embolectomy; TVR: Tricuspid valve replacement.

Table 4.

Patients with arrhythmia following medical termination of pregnancy

No.
Age
Clinical details
Arrythmia observed
Possible mechanism for arrythmia
Treatment given
Outcome
Ref.
1 NA, 2nd trimester Induced by PGF2a Bradycardia Drug induced hypokalemia NA NA [37]
2 32 yr, 20th wk gestation Induced by PGF2a Bradycardia and hypotension PG acting on ventricular receptor IV RL, 0.5 mg atropine no response F/u 1 mo EKG and echo normal [38]
3 37 yr, 10 wk gestation In miscarriage Bradyarrythmia POC through cervix trigger vagal stimulation POC removed EKG normal on F/u [39]
4 42 yr, 12 wk gestation Miscarriage, with lower abdominal pain Bradyarrythmia with hypotension. USG TVS: POC in UC POC through cervix, triggering vagus POC removed BP and HR improved [40]
5 Age: NA, 2nd trimester Induced by PGF2α and IV oxytocin Bradycardia, hypothermia and hypotension Rupture of the cervix NA NA [41]

PGF2a: Prostaglandin F2 alpha; NA: Not available; USG: Ultrasound; TVS: Transvaginal ultrasound; POC: Product of conception; UC: Uterine cavity; RL: Ringer lactate; F/u: Follow-up; EKG: Electrocardiogram; BP: Blood pressure; HR: Heart rate.

Table 2.

Patients with takotsubo cardiomyopathy following medical termination of pregnancy

No.
Age, gestation
Clinical feature
TTC criteria: EKG and Trop; echo; coronary angiography negative; pheochromocytoma
Possible pathophysiology
Treatment given
Outcome: Mortality and EF repeat
Ref.
1 36 yr, 12 wk gestation Misc; hypovolemia ECG: ST and Trop T elevated; eCHO: TTE (35%) EF, hypok LV apex; coronary angiography: Negative Catecholamine surge: (1) Direct toxicity; (2) Coronary vasoconstriction; and (3) Microvascular spasm IV furosemide 5th d repeat echo: LV to EF: 60%. F/u: 11 mo, no relapse [26]
2 22 yr, gestation: NA Post Sx TOP with evacuation of retained POC; hypovolemia EKG: Normal and Trop T elevated; 2D echo: DCM; coronary angiography: Negative Catecholamine release post procedure Diuretics. Bisoprolol and lisinopril Echo: Repeat day 2 had EF 56%. Follow-up, full recovery [27]
3 37 yr, Misc Chest pain, radiating to the neck EKG: ST depression, Trop T elevated; 2D echo: EF < 40%; coronary angiography: Negative NA NA F/u echo EF normal. F/u Trop T normal [28]
4 43 yr, gestation: NA Chest pain EKG: Normal and Trop T elevated; echo: LV hypokinesia, apical, diaphragmal, posterio-basal segments; coronary angiography: Negative Stress factors: (1) H/o fetal death at 18 wk gestation; and (2) Domestic stress Beta-blockers, ACE inhibitors, aspirin 5 d later, 2D echo EF 72%, normal wall movements. F/u: Developed 4 episodes of TTC, 6 mo, 9 mo, 10 mo, and 19 mo later. With eventual normalization of EF [29]
5 43 yr, 9 wk gestation Post Sx TOP. Shock, hypoxia, cardiac arrest requiring CPR EKG: T wave inv, Trop T elevated; echo: LV EF 33%, LV apex hypo/akinesia; angiography: NA h/o autoimmune diseases; post-op stress; cervical infiltration of epinephrine Infusion of levosimendan Echo: 3 mo later showed return of the LV function to normal [30]
6 28 yr, 12 wk gestation Chest pain EKG: T wave inv, Trop T elevated; echo: EF (30%-35%); hypokinesia mid ventricular and hyperKinesia apical and basal wall; coronary angiography: Negative Post abortion depression; suicidal ideation Carvedilol. Lisinopril spironolactone F/u echo: NA. Hemodynamically stable on follow-up [31]
7 32 yr, 10 + 1 wk gestation; Misc Abdominal pain, vaginal bleeding. Later underwent POC evacuation EKG: Intermittent VT and QRS broadening. Trop T: NA; TTE: EF: 32%, global LV hypokinesia and akinesia of inferior and inferioseptal wall; coronary angiogra gestation phy: Negative Septic miscarriage with blood C/S: Group C Streptococcus; amphetamine usage IV antibiotics Full recovery in 6 wk. 2D echo: Normal on repeat [32]

Misc: Miscarriage; POC: Product of conception; Sx TOP: Surgical termination of pregnancy; CPR: Cardiopulmonary resuscitation; ST: Sinus tachycardia; DCM: Dilated cardiomyopathy; VT: Ventricular tachycardia; Post-op: Post-operation; EF: Ejection fraction; LV: Left ventricle; TTC: Takotsubo cardiomyopathy; TTE: Transthoracic echocardiography; NA: Not available; EKG: Electrocardiogram; C/S: Culture and susceptibility; F/u: Follow-up.

Table 3.

Patients with spontaneous coronary artery dissection following medical termination of pregnancy

No.
Age
C/F and EKG
Labs and imaging
Angiography
Management and prognosis
Ref.
1 36 yr Chest pain 2 wk post abortion. ECG: STE in V2-V4, STD in inferior leads Cardiac biomarkers: Normal. Echo: Normal Angiography: Type C dissection in LAD Management: PCI with stenting to LAD. Survived, no similar episodes at follow-up after 8 mo [33]
2 41 yr 2 wk post still birth, became unresponsive, cardiac arrest post CPR, ROSC. ECG: STE in leads 2, 3, avF Cardiac biomarkers: Normal. Echo: Decreased LV contractility, EF: 30% Angiography: Type 2 SCAD involving distal RCA Management: Medical management. Survived post cardiac arrest, anoxic brain injury [34]
3 33 yr Chest pain 10 d post abortion. EKG: STE in inferior leads Cardiac biomarkers: Increased Angiography: Dissection involving RCA Management: PCI. Survived [35]
4 N/A 2 cases had SCAD a/w stillbirth and miscarriage N/A N/A N/A [36]

C/F: Clinical features; EKG: Electrocardiogram; N/A: Not applicable; STE: Sinus tachycardia elevation; STD: Sinus tachycardia depression; CPR: Cardiopulmonary resuscitation; ROSC: Return of spontaneous circulation; SCAD: Spontaneous coronary artery dissection; LV: Left ventricle; EF: Ejection fraction; LAD: Left anterior descending artery; RCA: Right coronary artery; PCI: Percutaneous coronary intervention.

Of the 16 cases of IE following abortion, 15 occurred following elective surgical abortion and one was a case of clandestine induced abortion. Only two patients had an underlying risk factor for IE, including a history of aortic valve replacement (AVR)/mitral valve replacement (MVR) for IE and rheumatic heart disease. The median age of these patients was 24 years[15-37]. Following termination of pregnancy, the initial clinical presentation occurred as early as one week after the abortion to as late as several weeks, with the most delayed presentation seen 60 d after the abortion. Data on prior antibiotic prophylaxis was available for 11 patients, four of whom received prophylaxis, including doxycycline in two cases, ampicillin and gentamicin in one, and a combination of ciprofloxacin and doxycycline in one. The tricuspid valve was the most commonly involved, as seen in 11 patients (69%), with multivalvular involvement in two patients and rare pulmonary valve involvement in one patient (6%). Group B Streptococcus (GBS) was the most common organism detected in these patients (n = 13, 81%), with culture being negative in one patient. Escherichia coli and methicillin sensitive Staphylococcus aureus were positive in one patient each. Most patients had IE related complications at the time of presentation, with the most common complication being septic emboli as seen in 69% (n = 11) followed by heart failure in 19% (n = 3). All patients were treated with intravenous antibiotics and 56% (n = 9) required surgical intervention, including MVR in two patients, tricuspid valve replacement in four, AVR in two, and pulmonary valve replacement in one. An embolectomy was performed on one patient, along with medical management. The prognosis for this subset of patients was good, with a mortality rate of 6% (n = 1) in Table 1[10-25].

TTC was reported in seven cases in the literature as a post-abortion CVD complication. The mean age at presentation was 34.4 years, with a range of 22 to 43 years. Of the four patients (57%) for whom gestational age was available, all had undergone an abortion or miscarriage in the first trimester (within less than 12 wk). Three (43%) patients had experienced miscarriages, two (29%) had undergone surgical termination of pregnancy, and one had undergone an elective abortion. One patient had a history of myoma removal surgery during the 14th wk of pregnancy, which resulted in fetal death four weeks later and led to five recurrent episodes of TTC that improved with follow-up care. The most common presentation in the emergency department was chest pain, which was reported by three (43%) patients, with one patient experiencing right-sided pain radiating to the neck and the other two experiencing severe left-sided, non-radiating acute pain. Other common presentations included hypotension (n = 1), abdominal pain, and vaginal bleeding (n = 1). Abnormal EKG finding was reported in three (43%) patients only. EKG findings in most patients were normal sinus rhythm (n = 2) or T wave inversion (n = 2) in the inferior and anteroseptal walls. Other EKG findings included up-sloping ST depression (n = 1) and sinus tachycardia (n = 1). Troponin levels were available and elevated in six (86%) patients. Coronary angiography was performed on six (86%) patients who did not show any evidence of obstructive coronary artery disease. Echocardiograms in all seven (100%) patients reported a reduced ejection fraction (EF) of less than 40%, with the most common wall involvement being the apex in 57% (n = 4) and basal wall in 29% (n = 2). Only 43% were started on guideline-directed medical therapy (n = 3). Treatment for these patients commonly included beta-blockers (BB) and angiotensin-converting-enzyme inhibitors (ACEi) in 43% (n = 3), and diuretics in 29% (n = 2). Other pharmacological agents used for treatments included aspirin, antibiotics, spironolactone, and levosimendan (n = 1 each). Six (87%) patients with available follow-up information had echocardiograms showing restoration of EF. Following the initial episode, one patient had five distinct episodes of TTC recurrence following an altercation with her partner. No recurrences were reported for the remaining patients, and there were no reported mortalities[26-32].

In four reported cases of SCAD following abortion or stillbirth, individual patient data was available for three patients. The median age of these patients was 36 years, with a range of 33 to 41 years. All three patients presented within 14 d of undergoing abortion or stillbirth. The most common clinical presentation was chest pain, which was reported by two patients (50%). EKG changes in these patients included ST elevation, with the most common leads involved being the inferior leads (50% of patients), mimicking acute myocardial infarction. Cardiac biomarkers were normal in all cases. Echocardiography was performed on two patients, with one showing normal findings and the other showing decreased left ventricle contractility with an EF of 30%. Coronary angiography showed dissection in the right coronary artery in two patients (one with proximal involvement and one with distal involvement) and the left anterior descending artery in one. Management included percutaneous coronary intervention besides medical management for two of the three patients. All three patients survived the event. One patient had no similar episode after eight months of follow-up, while the other patient had a remnant anoxic brain injury[33-36].

Out of five patients developing arrhythmia, the most common type reported was bradycardia which was seen in 60% (n = 3) of patients. Other two patients developed an arrhythmia post administration of prostaglandin F2 alpha drugs. The two patients who developed bradycardia did so after the passage of the product of conception (POC) and the application of pressure to their cervix. The mechanism which was speculated to cause this was the triggering of the vagus nerve during this process, resulting in the development of bradycardia. In all these patients, bradycardia improved after forceps assisted removal of the POC. There was also a patient who developed supraventricular tachycardia (SVT) after the administration of the misoprostol injection[37-41].

DISCUSSION

In the year 2020, the CDC reported rate of abortion was 11.2 abortions per 1000 women of age 15-44 years in the United States[1]. The type of abortion can also be classified as either being safe (performed in a safe, clean environment with experienced providers and no legal restrictions) or unsafe (performed with hazardous materials and techniques, by a person without the needed skills, or in an environment where minimal medical standards are not met)[42]. Abortion related complications and deaths occur predominantly in unsafe abortions and in settings where it is illegal[43]. Complications following an abortion can be diverse. The maternal mortality rate following safe, legal induced abortion for 2013-2019 was reported to be 0.43 deaths per 100000 reported legal abortions[1]. Pregnancy is a state of altered neuro-humoral balance and continuous inflammation with significant effects on the physiology of the CVD system[44-47]. It is probable that even abortion or stillbirth can also result in altered neuro-humoral balance and chronic inflammatory changes affecting the functioning of the CVD system[4,42]. In this descriptive review, we highlight the various CVD complications following MTP reported in the medical literature. We identified four distinct CVD complications following MTP, which have been defined as above (Figure 2).

Figure 2.

Figure 2

Cardiovascular complications following medical terminations of pregnancy. SCAD: Sudden coronary artery dissection; EKG: Electrocardiographic.

IE

In this review, IE was the most common CVD complication observed following MTP. While multiple organisms are reported to cause IE, in these patients the most common organism causing IE was GBS, which is a common colonizer of the genital tract and lower gastrointestinal tract[48,49]. The reported risk factors that predispose to GBS IE are diabetes mellitus, malignant disease, advanced liver disease, human immunodeficiency virus, alcohol use disorders, and injection drug use[50]. Surgical abortion has been reported to be an independent risk factor for IE in patients with GBS, irrespective of the presence or absence of underlying structural heart disease or antibiotic prophylaxis before the procedure[12,13]. The Society of Obstetricians and Gynaecologists of Canada recommends antimicrobial prophylaxis for patients who are undergoing surgical abortion to reduce the incidence of post-abortion infections[51]. This recommendation is based on a meta-analysis of 12 randomized controlled trials conducted in pregnant women at less than 16 wk gestation. Patients who received antibiotics during the abortion procedure had a 0.58 (0.47-0.71) relative risk of developing upper genital tract infection, compared to those who did not receive the antibiotics[52]. A single appropriate antibiotic regimen was not recommended in the study. Though antibiotic therapy has been shown to prevent genitourinary infections, antibiotics were not uniformly administered in the above subsets of patients. Clinicians providing MTP should be aware of this rare complication in patients with risk factors as mentioned above. So far there are no studies to guide antibiotic prophylaxis in patients undergoing MTP, however, patients with risk factors for developing GBS IE might benefit from pre-procedure prophylaxis. In a study done in Sweden on women undergoing an induced abortion, the administration of antibiotics reduced the post-abortion complications in patients with positive bacterial screening to the level with those having negative bacterial screening[53]. Despite the above study, given the rarity of this complication, prolonged prophylactic antibiotic courses are not feasible or evidence-based.

The most common valve involved was the tricuspid valve, but multivalvular involvement was also seen[15,17,21,54]. Pelvic infections occurring after a septic abortion can provide a portal of entry for bacteria through pelvic veins into the venous system. This can subsequently spread to the right-sided circulation, eventually causing tricuspid endocarditis. Most of these patients presented with constitutional symptoms like chills, anorexia, and weight loss. Complications including septic pulmonary emboli are common among patients with right-sided IE, occurring in up to 75% of patients with tricuspid involvement. Clinical manifestations of such emboli include cough, pleuritic chest pain, hemoptysis, and dyspnoea[42,55,56]. In our study, the common complications seen were septic emboli and heart failure. All patients were treated with appropriate antibiotics based on culture and sensitivity results[57-61]. Patients with septic emboli, paravalvular abscess, conduction blocks, and the presence of large vegetations required surgical management as shown in Table 1. Overall, the prognosis was good with a mortality of 6.25%.

TTC

TTC, also called transient apical ballooning syndrome, was initially described in Japan in 1990[62,63]. Improved access to coronary angiography has led to increased recognition of TTC in patients presenting with symptoms of acute coronary syndrome, with studies reporting a 20-fold increase in incidence from 2006 to 2012[64-66]. Mayo Clinic Criteria and International Takotsubo Diagnostic Criteria (InterTAK Diagnostic Criteria) are two of the most commonly used tools to establish the diagnosis[64,67]. In our study, Mayo Clinic Criteria was used. TTC has been reported to be precipitated in 70% of patients by several acute triggers including emotional, natural disaster, illness, envenomation, infection, etc.[68-70]. In this paper we discuss TTC precipitated following MTP. Patients who developed TTC post MTP presented with symptoms and signs of ACS including chest pain, ST-T wave changes in EKG, and elevated troponin as seen in patients with other precipitators of TTC[71]. In this review apical wall involvement was the most common echocardiographic abnormality, as reported by Templin et al[64] in 81.7% of their patient population (n = 1750)[72]. Multiple mechanisms have been proposed to precipitate TTC[72]. The various mechanisms postulated to precipitate TTC in this review were catecholamine surge following physical and emotional distress (depression, posttraumatic stress disorder, and suicidal ideation) and exogenous epinephrine[26,31,32]. It has been hypothesized that direct myocardial damage from catecholamines may cause TTC and the regional wall motion abnormalities occur due to the regional distribution of adrenergic receptors. At presentation all these patients had low left ventricular EF, however, less than half of the patients were treated with guideline directed medical therapy with ACEi and BB. Interestingly, no mortality was reported and at follow-up all these patients were found to have normal left ventricular ejection fraction.

SCAD

SCAD is a rare condition, with an estimated prevalence of 0.2% to 1.1%[49,73]. The prevalence of SCAD post pregnancy, stillbirth, and abortion remains unknown. There are several proposed mechanisms for the development of SCAD in these situations, including structural changes to the vascular system due to excess progesterone during pregnancy leading to the loss of normal corrugation of elastic fibers, increasing the fragmentation of reticular fibres, and decreasing the amounts of mucopolysaccharides reducing the strength of vessel wall, increased mechanical stress on the coronary artery during labor, prolonged coronary artery spasm, and the use of uterotonic drugs[36,74-77]. Maternal risk factors, such as multiple pregnancies, advanced age, and anxiety, may also increase the risk of SCAD due to repeated exposure to high levels of progesterone and altered neuro-hormonal balance[74,75,77]. In this review, SCAD was reported within 2 wk of MTP presenting as an ACS. Although the risk of SCAD post pregnancy and stillbirth may differ, early intervention with high clinical suspicion can result in good outcomes, as reported in various studies[44,73,78].

Arrhythmia

Bradycardia was the most common arrhythmia observed in our review[35-37,47]. The common cause of bradycardia is vagal stimulation during the passage of the fetus or POC through the cervix, a phenomenon known as cervical vasovagal shock[39,40]. This is typically observed with retained POC, and management often involves dilatation and curettage to remove the POC. In a study conducted in Cambridge, Kyejo et al[40] suggest that for patients with symptomatic bradycardia secondary to cervical shock, it is important to stop cervical manipulation and remove all instruments, keep the patient in the supine position with legs elevated to improve venous return, and, if necessary, administer 500-600 microgram of IV atropine followed by a saline flush. In this review, removal of the POC with forceps improved shock and bradycardia. Other causes of arrhythmia observed in our patients include prostaglandin F2 and E (misoprostol), which have been linked to tachycardia and SVT. A study in mice suggests that these medications may cause tachyarrhythmias due to their direct effect of inflammatory mediators on the heart[79]. Stopping the medications resulted in the improvement of arrhythmias in these patients.

This review has several limitations. It included all the patients with MTP and reported CVD complications from various case reports over the years, which had varied uniformity in reporting. These patients were young and lacked baseline echocardiography or electrocardiography. All the reports of SCAD and TTC consistently did not report cardiac catheterization results[80]. Reports did not mention functional status at discharge, recurrence, and long-term follow-up details[81-84]. However, the strengths of this study are: (1) Having a strict inclusion criterion for each clinical entity; and (2) Evidence-based detailing on the clinical profile and the outcome of each described complication. As per the authors’ knowledge, there are previous studies done including Kyriacou et al[3] who have reported that women with previous pregnancy loss, following a miscarriage, stillbirth, and induced abortion, are at higher risk of coronary heart disease and stroke. However, this is the first review detailing the clinical profile, imaging details, complications, and outcomes of the various CVD complications following MTP.

CONCLUSION

In conclusion, CVD complications are uncommon following MTP. The most frequently reported complications are IE and TTC. IE can occur in these subgroups of patients without risk factors for IE. Periprocedural antibiotics prophylaxis was not uniformly administered. IE can occur within 1 wk of MTP, and the most common organism identified is GBS. The most commonly involved valve reported is the tricuspid valve, and the most common complication reported is septic emboli. More than half of the IE patients required surgical intervention owing to worsening heart failure, valvular regurgitation, para valvular abscess, conduction block, and embolic phenomenon. TTC most commonly occurred after MTP in the first trimester. Most patients presented with acute chest pain, troponin elevation, and nonspecific ST-T changes. The most common pattern of TTC as identified by echocardiography was apical. All these patients had low EF at presentation and at follow-up most had normal EF even though only half of them were treated with ACEi and BB. SCAD occurred within 2 wk of MTP. Most patients presented with chest pain and EKG abnormalities. The most common vessel involved in dissection was the right coronary artery. Bradycardia was the most common pattern of arrhythmia noted and occurred during the time of MTP and was self-limiting. All patients with the above complications improved with appropriate medical management. Overall, mortality was low in this population.

ARTICLE HIGHLIGHTS

Research background

Millions of medical terminations of pregnancy (MTP) take place yearly in the United States of America with a smaller percentage of this population developing complications. There is a lack of structured reporting of the cardiovascular (CVD) complications in this subset of patients.

Research motivation

The CVD complications occurring post MTP or after stillbirth are not very well described. The literature on the various CVD comorbidity following MTP is scanty.

Research objectives

In this review we aimed to study the various cardiac comorbidities seen after MTP, which will help the reader better understand, prepare, and manage these complications.

Research methods

A literature search in multiple databases including PubMed, Medline, RCA and google scholar, using the search terms “abortions” or “medical/Legal termination of pregnancy” and “cardiac complications” or “cardiovascular complications” were conducted. All research studies, clinical studies, case series, and case reports with relevant clinical details were included.

Research results

The most common complications described in the literature following MTP were infective endocarditis (IE), takotsubo cardiomyopathy (TTC), arrhythmia, and sudden coronary artery dissection (SCAD). The most common valve involved in IE was the tricuspid valve. The most observed causative organism of endocarditis was group B Streptococcus. The most common type of TTC was apical. Bradycardia was the most common arrhythmia. All four cases of SCAD-P type presented as acute coronary syndrome with predominant involvement of the right coronary artery. Mortality was only reported following IE in 6.25%. Clinical recovery occurred after optimal medical management following all these complications.

Research conclusions

The most common CVD complications following the MTP are IE, TTC, bradycardia, and SCAD. Most of these complications are adequately treated with appropriate medical management.

Research perspectives

As per the authors’ knowledge, this is the first review detailing on the clinical profile, imaging details, complications, and outcomes of the various CVD complications following MTP.

Footnotes

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Peer-review started: June 15, 2023

First decision: August 10, 2023

Article in press: September 18, 2023

Specialty type: Cardiac and cardiovascular systems

Country/Territory of origin: United States

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): D, D

Grade E (Poor): 0

P-Reviewer: Amir M, Indonesia; Papadopoulos VP, Greece; Zhang XQ, China S-Editor: Wang JJ L-Editor: Wang TQ P-Editor: Wang JJ

Contributor Information

Tejveer Singh, Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States.

Ajay K Mishra, Division of Cardiology, Saint Vincent Hospital, Worcester, MA 01608, United States. ajay.mishra@stvincenthospital.com.

Nikhil Vojjala, Department of Internal Medicine, Post-Graduation Institute of Medical Education and Research, Chandigarh 00000, India.

Kevin John John, Department of Internal Medicine, Tufts Medical Center, Boston, MA 01212, United States.

Anu A George, Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States.

Anil Jha, Division of Cardiology, Saint Vincent Hospital, Worcester, MA 01608, United States.

Michelle Hadley, Division of Cardiology, Saint Vincent Hospital, Worcester, MA 01608, United States.

References

  • 1.Kortsmit K, Nguyen AT, Mandel MG, Clark E, Hollier LM, Rodenhizer J, Whiteman MK. Abortion Surveillance - United States, 2020. MMWR Surveill Summ. 2022;71:1–27. doi: 10.15585/mmwr.ss7110a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Muehlschlegel C, Kyriacou H, Al-Mohammad A, Foster-Davies LA, Simmons-Jones F, Oliver-Williams C. The risk of cardiovascular disease in women after miscarriage, stillbirth, and therapeutic abortion: a protocol for a systematic review and meta-analysis. Syst Rev. 2020;9:234. doi: 10.1186/s13643-020-01444-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kyriacou H, Al-Mohammad A, Muehlschlegel C, Foster-Davies L, Bruco MEF, Legard C, Fisher G, Simmons-Jones F, Oliver-Williams C. The risk of cardiovascular diseases after miscarriage, stillbirth, and induced abortion: a systematic review and meta-analysis. Eur Heart J Open. 2022;2:oeac065. doi: 10.1093/ehjopen/oeac065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sajadi-Ernazarova KR, Martinez CL. Abortion Complications. 2023 May 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan- [Google Scholar]
  • 5.Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132:1435–1486. doi: 10.1161/CIR.0000000000000296. [DOI] [PubMed] [Google Scholar]
  • 6.Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, Ganesh SK, Gulati R, Lindsay ME, Mieres JH, Naderi S, Shah S, Thaler DE, Tweet MS, Wood MJ American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation. 2018;137:e523–e557. doi: 10.1161/CIR.0000000000000564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mishra AK, Sahu KK, Lal A. Significance of prolonged PR interval in infections. QJM. 2020;113:150–151. doi: 10.1093/qjmed/hcz192. [DOI] [PubMed] [Google Scholar]
  • 8.Forero DA, Lopez-Leon S, González-Giraldo Y, Bagos PG. Ten simple rules for carrying out and writing meta-analyses. PLoS Comput Biol. 2019;15:e1006922. doi: 10.1371/journal.pcbi.1006922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994;120:667–676. doi: 10.7326/0003-4819-120-8-199404150-00008. [DOI] [PubMed] [Google Scholar]
  • 10.Codjo LH, Savi de Tove KM, Hounkponou FA, Dohou SH, Houenassi MD. Endocarditis tricuspid sub-aigue of post abortion: report of a case. Cardiovasc J Afr. 2015;26:e6–e8. doi: 10.5830/CVJA-2015-023. [DOI] [PubMed] [Google Scholar]
  • 11.Kishan R, Wesley S, Barnett G, Kauffman RP. Septic abortion complicated by infective endocarditis, mitral valve vegetation, and septic and reactive arthritis: A case report. Case Rep Womens Health. 2022;34:e00398. doi: 10.1016/j.crwh.2022.e00398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Billick M, Gold WL. Group B streptococcal endocarditis following elective surgical abortion. CMAJ. 2019;191:E916–E918. doi: 10.1503/cmaj.181688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Crespo A, Retter AS, Lorber B. Group B streptococcal endocarditis in obstetric and gynecologic practice. Infect Dis Obstet Gynecol. 2003;11:109–115. doi: 10.1080/10647440300025507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Atri ML, Cohen DH. Group B streptococcus endocarditis following second-trimester abortion. Arch Intern Med. 1990;150:2579–2580. [PubMed] [Google Scholar]
  • 15.Vartian CV, Septimus EJ. Tricuspid valve group B streptococcal endocarditis following elective abortion. Rev Infect Dis. 1991;13:997–998. doi: 10.1093/clinids/13.5.997. [DOI] [PubMed] [Google Scholar]
  • 16.Azzam ZS, Ron Y, Oren I, Sbeit W, Motlak D, Krivoy N. Group B streptococcal tricuspid valve endocarditis: a case report and review of literature. Int J Cardiol. 1998;64:259–263. doi: 10.1016/s0167-5273(98)00052-7. [DOI] [PubMed] [Google Scholar]
  • 17.Kangavari S, Collins J, Cercek B, Atar S, Siegel R. Tricuspid valve group B streptococcal endocarditis after an elective termination of pregnancy. Clin Cardiol. 2000;23:301–303. doi: 10.1002/clc.4960230418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Camarillo D, Banerjee R, Greenhow TL, Tureen JH. Group B streptococcal endocarditis after elective abortion in an adolescent. Pediatr Infect Dis J. 2009;28:67–69. doi: 10.1097/INF.0b013e31818128f5. [DOI] [PubMed] [Google Scholar]
  • 19.Listernick R. A 15-year-old girl with a fever following an abortion. Pediatr Ann. 2005;34:264–266, 268. doi: 10.3928/0090-4481-20050401-06. [DOI] [PubMed] [Google Scholar]
  • 20.Piedimonte S, Almohammadi M, Lee TC. Group B Streptococcus tricuspid valve endocarditis with subsequent septic embolization to the pulmonary artery: A case report following elective abortion. Obstet Med. 2018;11:39–44. doi: 10.1177/1753495X17714711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Palys EE, Li J, Gaut PL, Hardy WD. Tricuspid valve endocarditis with Group B Streptococcus after an elective abortion: the need for new data. Infect Dis Obstet Gynecol. 2006;2006:43253. doi: 10.1155/IDOG/2006/43253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jeppson PC, Park A, Chen CC. Multivalvular bacterial endocarditis after suction curettage abortion. Obstet Gynecol. 2008;112:452–455. doi: 10.1097/AOG.0b013e3181663051. [DOI] [PubMed] [Google Scholar]
  • 23.McKenna T, O'Brien K. Case report: group B streptococcal bacteremia and sacroiliitis after mid-trimester dilation and evacuation. J Perinatol. 2009;29:643–645. doi: 10.1038/jp.2009.19. [DOI] [PubMed] [Google Scholar]
  • 24.Maturu MV, Devasia T, Rao MS, Kareem H. Native Triple Valve Endocarditis as Complication of Post-Abortal Sepsis. J Clin Diagn Res. 2016;10:OD08–OD09. doi: 10.7860/JCDR/2016/20551.8147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Anjum Z, Tariq Z. Escherichia coli-associated Infective Endocarditis in a Patient with Septic Abortion: A Rare Culprit in a Unique Presentation. Cureus. 2019;11:e5632. doi: 10.7759/cureus.5632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gemenetzis G, Gourgiotis S, Aravosita P, Mystakelli C, Aloizos S. Takotsubo cardiomyopathy: a hidden enemy of the hypovolemic patient? Am J Emerg Med. 2013;31:262.e5–262.e7. doi: 10.1016/j.ajem.2012.03.029. [DOI] [PubMed] [Google Scholar]
  • 27.Dessain T, Stewart R, Patil S. Postoperative cardiogenic shock secondary to Takotsubo's syndrome. BMJ Case Rep. 2019;12 doi: 10.1136/bcr-2019-233055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Novograd J, Goldstein B, Itzkowitz Y, Insel J. Takotsubo and troponin: a conflicting tale-an extreme case of stress induced cardiomyopathy. J Am Coll Cardiol. 2021;77:814. [Google Scholar]
  • 29.Hefner J, Csef H, Frantz S, Glatter N, Warrings B. Recurrent Tako-Tsubo cardiomyopathy (TTC) in a pre-menopausal woman: late sequelae of a traumatic event? BMC Cardiovasc Disord. 2015;15:3. doi: 10.1186/1471-2261-15-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jothin A, Raj JP, Thiruvenkatarajan V. A simple procedure in a complex patient: perioperative takotsubo cardiomyopathy. BMJ Case Rep. 2020;13 doi: 10.1136/bcr-2019-233121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Agrawal Y, Zoltowska DM, Halabi A. Mid-ventricular takotsubo cardiomyopathy triggered by major depressive disorder after abortion. BMJ Case Rep. 2018;2018 doi: 10.1136/bcr-2018-226977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jih W, Walker G, Deonarine P, Wong LFA. Takotsubo cardiomyopathy associated with Group C Streptococcus septic miscarriage: a case report. J Obstet Gynaecol. 2022;42:2522–2523. doi: 10.1080/01443615.2022.2028274. [DOI] [PubMed] [Google Scholar]
  • 33.Salari A, Gholipur M, Rezaeidanesh M, Barzigar A, Rahmani S, Pursadeghi M, Ebrahimi H. A 36-Year-Old Woman with Coronary Artery Dissection Two Weeks after Abortion. J Tehran Heart Cent. 2016;11:98–101. [PMC free article] [PubMed] [Google Scholar]
  • 34.Numasawa Y, Yokokura S, Maeda T, Daigo K, Sakata S, Hashimoto R, Taruoka A, Sato K, Haginiwa S, Kojima H, Tanaka M. A woman complicated by sudden cardiac arrest owing to spontaneous coronary artery dissection after stillbirth. J Cardiol Cases. 2021;23:61–64. doi: 10.1016/j.jccase.2020.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Iltumur K, Karahan Z, Ozmen S, Danis R, Toprak N. Spontaneous coronary artery dissection during hemodialysis in the post-abortion period. Int J Cardiol. 2008;127:e45–e47. doi: 10.1016/j.ijcard.2007.01.105. [DOI] [PubMed] [Google Scholar]
  • 36.Tweet MS, Hayes SN, Codsi E, Gulati R, Rose CH, Best PJM. Spontaneous Coronary Artery Dissection Associated With Pregnancy. J Am Coll Cardiol. 2017;70:426–435. doi: 10.1016/j.jacc.2017.05.055. [DOI] [PubMed] [Google Scholar]
  • 37.Burt RL, Connor ED, Davidson IW. Hypokalemia and cardiac arrhythmia associated with prostaglandin-induced abortion. Obstet Gynecol. 1977;50 [PubMed] [Google Scholar]
  • 38.Habek JA, Habek D, Gulin D. Refractory bradycardia--a rare complication of carboprost tromethamine for induction of abortion. Acta Clin Croat. 2016;55:323–325. doi: 10.20471/acc.2016.55.02.21. [DOI] [PubMed] [Google Scholar]
  • 39.Birch JD, Gulati D, Mandalia S. Cervical shock: a complication of incomplete abortion. BMJ Case Rep. 2017;2017 doi: 10.1136/bcr-2017-220452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kyejo W, Moshi B, Kapesi V, Ntiyakunze G, Gidion D, Kaguta M. Cervical vasovagal shock: A rare complication of incomplete abortion case report. Int J Surg Case Rep. 2022;97:107455. doi: 10.1016/j.ijscr.2022.107455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ylöstalo P, Kauppila E, Vapaatalo H. Complications following the intra-amniotic administration of prostaglandin f-2-alpha for therapeutic abortion. Acta Obstet Gynecol Scand. 1974;53:279–282. doi: 10.3109/00016347409162173. [DOI] [PubMed] [Google Scholar]
  • 42.Bridwell RE, Long B, Montrief T, Gottlieb M. Post-abortion Complications: A Narrative Review for Emergency Clinicians. West J Emerg Med. 2022;23:919–925. doi: 10.5811/westjem.2022.8.57929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Melese T, Habte D, Tsima BM, Mogobe KD, Chabaesele K, Rankgoane G, Keakabetse TR, Masweu M, Mokotedi M, Motana M, Moreri-Ntshabele B. High Levels of Post-Abortion Complication in a Setting Where Abortion Service Is Not Legalized. PLoS One. 2017;12:e0166287. doi: 10.1371/journal.pone.0166287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Havakuk O, Goland S, Mehra A, Elkayam U. Pregnancy and the Risk of Spontaneous Coronary Artery Dissection: An Analysis of 120 Contemporary Cases. Circ Cardiovasc Interv. 2017;10 doi: 10.1161/CIRCINTERVENTIONS.117.004941. [DOI] [PubMed] [Google Scholar]
  • 45.Rotondo JC, Oton-Gonzalez L, Selvatici R, Rizzo P, Pavasini R, Campo GC, Lanzillotti C, Mazziotta C, De Mattei M, Tognon M, Martini F. SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women. Front Cell Dev Biol. 2020;8:550543. doi: 10.3389/fcell.2020.550543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sorriento D, Iaccarino G. Inflammation and Cardiovascular Diseases: The Most Recent Findings. Int J Mol Sci. 2019;20 doi: 10.3390/ijms20163879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Henein MY, Vancheri S, Longo G, Vancheri F. The Role of Inflammation in Cardiovascular Disease. Int J Mol Sci. 2022;23 doi: 10.3390/ijms232112906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Thomas VV, Mishra AK, Jasmine S, Sathyendra S. Gram-negative infective endocarditis: a retrospective analysis of 10 years data on clinical spectrum, risk factor and outcome. Monaldi Arch Chest Dis. 2020;90 doi: 10.4081/monaldi.2020.1359. [DOI] [PubMed] [Google Scholar]
  • 49.Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae) Microbiol Spectr. 2019;7 doi: 10.1128/microbiolspec.gpp3-0007-2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chihara S, Siccion E. Group B streptococcus endocarditis with endophthalmitis. Mayo Clin Proc. 2005;80:74. doi: 10.1016/S0025-6196(11)62961-3. [DOI] [PubMed] [Google Scholar]
  • 51.Van Eyk N, van Schalkwyk J INFECTIOUS DISEASES COMMITTEE. Antibiotic prophylaxis in gynaecologic procedures. J Obstet Gynaecol Can. 2012;34:382–391. doi: 10.1016/S1701-2163(16)35222-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 1996;87:884–890. [PubMed] [Google Scholar]
  • 53.Carlsson I, Breding K, Larsson PG. Complications related to induced abortion: a combined retrospective and longitudinal follow-up study. BMC Womens Health. 2018;18:158. doi: 10.1186/s12905-018-0645-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sahu KK, Mishra AK, Sherif AA, Doshi A, Koirala B. An interesting case of pacemaker endocarditis. Neth Heart J. 2019;27:585–586. doi: 10.1007/s12471-019-01310-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Mishra AK, Sahu KK, Lal A, Sujata M. Systemic embolization following fungal infective endocarditis. QJM. 2020;113:233–235. doi: 10.1093/qjmed/hcz274. [DOI] [PubMed] [Google Scholar]
  • 56.Sahu KK, Mishra AK, Lal A, Kranis M. An interesting case of expressive aphasia: Enterococcus faecalis-related infective endocarditis complicating as septic emboli. QJM. 2020;113:146–147. doi: 10.1093/qjmed/hcz169. [DOI] [PubMed] [Google Scholar]
  • 57.Mishra A, Sahu KK, Abraham BM, Sargent J, Kranis MJ, George SV, Abraham G. Predictors, patterns and outcomes following Infective endocarditis and stroke. Acta Biomed. 2022;93:e2022203. doi: 10.23750/abm.v93i2.10185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.George A, Alampoondi Venkataramanan SV, John KJ, Mishra AK. Infective endocarditis and COVID -19 coinfection: An updated review. Acta Biomed. 2022;93:e2022030. doi: 10.23750/abm.v93i1.10982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Mishra AK, Sahu KK, Baddam V, Sargent J. Stroke and infective endocarditis. QJM. 2020;113:515–516. doi: 10.1093/qjmed/hcaa098. [DOI] [PubMed] [Google Scholar]
  • 60.Mishra AK, Sahu KK, Lal A, Menon V. Aortic valve abscess: Staphylococcus epidermidis and infective endocarditis. QJM. 2020;113:211–212. doi: 10.1093/qjmed/hcz151. [DOI] [PubMed] [Google Scholar]
  • 61.Bakhit A, Mishra AK, Choudhary K, Khaled Soufi M. Aortic root fistula complicating Austrian syndrome. Monaldi Arch Chest Dis. 2021;91 doi: 10.4081/monaldi.2021.1834. [DOI] [PubMed] [Google Scholar]
  • 62.Y-Hassan S, Yamasaki K. History of takotsubo syndrome: is the syndrome really described as a disease entity first in 1990? Some inaccuracies. Int J Cardiol. 2013;166:736–737. doi: 10.1016/j.ijcard.2012.09.183. [DOI] [PubMed] [Google Scholar]
  • 63.John K, Lal A, Mishra A. A review of the presentation and outcome of takotsubo cardiomyopathy in COVID-19. Monaldi Arch Chest Dis. 2021;91 doi: 10.4081/monaldi.2021.1710. [DOI] [PubMed] [Google Scholar]
  • 64.Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015;373:929–938. doi: 10.1056/NEJMoa1406761. [DOI] [PubMed] [Google Scholar]
  • 65.Li P, Li C, Mishra AK, Cai P, Lu X, Sherif AA, Jin L, Wang B. Impact of malnutrition on in-hospital outcomes in takotsubo cardiomyopathy. Nutrition. 2022;93:111495. doi: 10.1016/j.nut.2021.111495. [DOI] [PubMed] [Google Scholar]
  • 66.George AA, Mishra AK, Sargent J. Letter to the Editor Regarding "Pipeline Embolization in Patients with Posterior Circulation Subarachnoid Hemorrhages: Is Takotsubo Cardiomyopathy a Limiting Factor?". World Neurosurg. 2020;144:303–304. doi: 10.1016/j.wneu.2020.08.110. [DOI] [PubMed] [Google Scholar]
  • 67.Mishra AK, George AA, John KJ, Arun Kumar P, Dasari M, Afraz Pasha M, Hadley M. Takotsubo cardiomyopathy following envenomation: An updated review. World J Cardiol. 2023;15:33–44. doi: 10.4330/wjc.v15.i1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.George AA, John KJ, Jha A, Mishra AK. Infections precipitating Takotsubo cardiomyopathy, an uncommon complication of a common infection. Monaldi Arch Chest Dis. 2022;93 doi: 10.4081/monaldi.2022.2408. [DOI] [PubMed] [Google Scholar]
  • 69.George AA, John KJ, Selvaraj V, Mishra AK. Endocrinological abnormalities and Takotsubo cardiomyopathy. Monaldi Arch Chest Dis. 2021;91 doi: 10.4081/monaldi.2021.1859. [DOI] [PubMed] [Google Scholar]
  • 70.Sahu KK, Mishra AK, Doshi A, Martin KB. Heart broken twice: a case of recurrent Takatsubo cardiomyopathy. BMJ Case Rep. 2020;13 doi: 10.1136/bcr-2019-232253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Sahu KK, Mishra AK, Lal A. Newer Insights Into Takotsubo Cardiomyopathy. Am J Med. 2020;133:e318. doi: 10.1016/j.amjmed.2019.11.008. [DOI] [PubMed] [Google Scholar]
  • 72.Nayar J, John K, Philip A, George L, George A, Lal A, Mishra A. A Review of Nuclear Imaging in Takotsubo Cardiomyopathy. Life (Basel) 2022;12 doi: 10.3390/life12101476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Hering D, Piper C, Hohmann C, Schultheiss HP, Horstkotte D. Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection. Z Kardiol. 1998;87:961–970. doi: 10.1007/s003920050253. [DOI] [PubMed] [Google Scholar]
  • 74.Saw J, Aymong E, Sedlak T, Buller CE, Starovoytov A, Ricci D, Robinson S, Vuurmans T, Gao M, Humphries K, Mancini GB. Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv. 2014;7:645–655. doi: 10.1161/CIRCINTERVENTIONS.114.001760. [DOI] [PubMed] [Google Scholar]
  • 75.Slight R, Behranwala AA, Nzewi O, Sivaprakasam R, Brackenbury E, Mankad P. Spontaneous coronary artery dissection: a report of two cases occurring during menstruation. N Z Med J. 2003;116:U585. [PubMed] [Google Scholar]
  • 76.Koul AK, Hollander G, Moskovits N, Frankel R, Herrera L, Shani J. Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature. Catheter Cardiovasc Interv. 2001;52:88–94. doi: 10.1002/1522-726x(200101)52:1<88::aid-ccd1022>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  • 77.Gowda RM, Sacchi TJ, Khan IA. Clinical perspectives of the primary spontaneous coronary artery dissection. Int J Cardiol. 2005;105:334–336. doi: 10.1016/j.ijcard.2004.11.029. [DOI] [PubMed] [Google Scholar]
  • 78.Nishikawa H, Nakanishi S, Nishiyama S, Nishimura S, Kato K, Yanagishita Y, Hosoi T, Seki A, Yamaguchi H. Primary coronary artery dissection: its incidence, mode of the onset and prognostic evaluation. J Cardiol. 1988;18:307–317. [PubMed] [Google Scholar]
  • 79.Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, Kuriyama S, Karibe H, Okada Y, Takahata O, Taniguchi T, Iijima T, Iwasaki H, Narumiya S, Ushikubi F. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med. 2005;11:562–566. doi: 10.1038/nm1231. [DOI] [PubMed] [Google Scholar]
  • 80.Jha A, Ojha CP, Bhattad PB, Sharma A, Thota A, Mishra AK, Krishnan AM, Roumia M. ST elevation myocardial infarction - national trend analysis with mortality differences in outcomes based on day of hospitalization. Coron Artery Dis. 2023;34:119–126. doi: 10.1097/MCA.0000000000001211. [DOI] [PubMed] [Google Scholar]
  • 81.Mishra AK, Abraham BM, Sahu KK, George AA, Sargent J, Kranis MJ, George SV, Abraham GM. Harms and Contributors of Leaving Against Medical Advice in Patients With Infective Endocarditis. J Patient Saf. 2022;18:756–759. doi: 10.1097/PTS.0000000000001055. [DOI] [PubMed] [Google Scholar]
  • 82.Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C, Omerovic E. Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;77:902–921. doi: 10.1016/j.jacc.2020.10.060. [DOI] [PubMed] [Google Scholar]
  • 83.Mehawej J, Mishra A, Saczynski JS, Waring ME, Lessard D, Abu HO, La V, Tisminetzky M, Tran KV, Hariri E, Filippaios A, Paul T, Soni A, Wang W, Ding EY, Bamgbade BA, Mathew J, Kiefe C, Goldberg RJ, McManus DD. Online health information seeking, low atrial fibrillation-related quality of life, and high perceived efficacy in patient-physician interactions in older adults with atrial fibrillation. Cardiovasc Digit Health J. 2022;3:118–125. doi: 10.1016/j.cvdhj.2022.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.George AA, Singh T, Bhattad PB, Sherif AA, Mishra AK. Serratia endocarditis, uncommon organism, with significant complications. Monaldi Arch Chest Dis. 2023 doi: 10.4081/monaldi.2023.2453. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Cardiology are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES